Literature DB >> 16825354

Identification and characterization of bacterial pathogens causing bloodstream infections by DNA microarray.

Berit E E Cleven1, Maria Palka-Santini, Jörg Gielen, Salima Meembor, Martin Krönke, Oleg Krut.   

Abstract

Bloodstream infections are potentially life-threatening and require rapid identification and antibiotic susceptibility testing of the causative pathogen in order to facilitate specific antimicrobial therapy. We developed a prototype DNA microarray for the identification and characterization of three important bacteremia-causing species: Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. The array consisted of 120 species-specific gene probes 200 to 800 bp in length that were amplified from recombinant plasmids. These probes represented genes encoding housekeeping proteins, virulence factors, and antibiotic resistance determinants. Evaluation with 42 clinical isolates, 3 reference strains, and 13 positive blood cultures revealed that the DNA microarray was highly specific in identifying S. aureus, E. coli, and P. aeruginosa strains and in discriminating them from closely related gram-positive and gram-negative bacterial strains also known to be etiological agents of bacteremia. We found a nearly perfect correlation between phenotypic antibiotic resistance determined by conventional susceptibility testing and genotypic antibiotic resistance by hybridization to the S. aureus resistance gene probes mecA (oxacillin-methicillin resistance), aacA-aphD (gentamicin resistance), ermA (erythromycin resistance), and blaZ (penicillin resistance) and the E. coli resistance gene probes blaTEM-106 (penicillin resistance) and aacC2 (aminoglycoside resistance). Furthermore, antibiotic resistance and virulence gene probes permitted genotypic discrimination within a species. This novel DNA microarray demonstrates the feasibility of simultaneously identifying and characterizing bacteria in blood cultures without prior amplification of target DNA or preidentification of the pathogen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16825354      PMCID: PMC1489523          DOI: 10.1128/JCM.02291-05

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

1.  Nosocomial spread of an unusual methicillin-resistant Staphylococcus aureus clone that is sensitive to all non-beta-lactam antibiotics, including tobramycin.

Authors:  S Pournaras; A Slavakis; A Polyzou; D Sofianou; A N Maniatis; A Tsakris
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Fluorescent In situ hybridization allows rapid identification of microorganisms in blood cultures.

Authors:  V A Kempf; K Trebesius; I B Autenrieth
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 3.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Rapid diagnosis of bacteremia by universal amplification of 23S ribosomal DNA followed by hybridization to an oligonucleotide array.

Authors:  R M Anthony; T J Brown; G L French
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

5.  Rapid identification of bacteria in blood cultures by using fluorescently labeled oligonucleotide probes.

Authors:  G J Jansen; M Mooibroek; J Idema; H J Harmsen; G W Welling; J E Degener
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

6.  Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis.

Authors:  F Martineau; F J Picard; N Lansac; C Ménard; P H Roy; M Ouellette; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

7.  Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing.

Authors:  J Barenfanger; C Drake; G Kacich
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

8.  Three days of incubation may be sufficient for routine blood cultures with BacT/Alert FAN blood culture bottles.

Authors:  P P Bourbeau; J K Pohlman
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

9.  Predominance of a methicillin-resistant Staphylococcus aureus clone susceptible to erythromycin and several other non-beta-lactam antibiotics in a Greek hospital.

Authors:  A Polyzou; A Slavakis; S Pournaras; A N Maniatis; D Sofianou; A Tsakris
Journal:  J Antimicrob Chemother       Date:  2001-08       Impact factor: 5.790

10.  Microarray analysis of microbial virulence factors.

Authors:  V Chizhikov; A Rasooly; K Chumakov; D D Levy
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

View more
  41 in total

1.  Evaluation of one- and two-color gene expression arrays for microbial comparative genome hybridization analyses in routine applications.

Authors:  Roland Schwarz; Biju Joseph; Gabriele Gerlach; Anja Schramm-Glück; Kathrin Engelhard; Matthias Frosch; Tobias Müller; Christoph Schoen
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

2.  Multiplexed identification of blood-borne bacterial pathogens by use of a novel 16S rRNA gene PCR-ligase detection reaction-capillary electrophoresis assay.

Authors:  Maneesh R Pingle; Kathleen Granger; Philip Feinberg; Rebecca Shatsky; Bram Sterling; Mark Rundell; Eric Spitzer; Davise Larone; Linnie Golightly; Francis Barany
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

3.  Comparison between two PCR-based bacterial identification methods through artificial neural network data analysis.

Authors:  Jie Wen; Xiaohui Zhang; Peng Gao; Qiuhong Jiang
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

Review 4.  Basic concepts of microarrays and potential applications in clinical microbiology.

Authors:  Melissa B Miller; Yi-Wei Tang
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

5.  Real-time optical antimicrobial susceptibility testing.

Authors:  Marlene Fredborg; Klaus R Andersen; Erik Jørgensen; Aida Droce; Tom Olesen; Bent B Jensen; Flemming S Rosenvinge; Teis E Sondergaard
Journal:  J Clin Microbiol       Date:  2013-04-17       Impact factor: 5.948

6.  Development and validation of a resistance and virulence gene microarray targeting Escherichia coli and Salmonella enterica.

Authors:  Margaret A Davis; Ji Youn Lim; Yesim Soyer; Heather Harbottle; Yung-Fu Chang; Daniel New; Lisa H Orfe; Thomas E Besser; Douglas R Call
Journal:  J Microbiol Methods       Date:  2010-03-31       Impact factor: 2.363

7.  Klebsiella pneumoniae antibiotic resistance identified by atomic force microscopy.

Authors:  Vincenzo Ierardi; Paolo Domenichini; Silvia Reali; Gian Marco Chiappara; Gianluigi Devoto; Ugo Valbusa
Journal:  J Biosci       Date:  2017-12       Impact factor: 1.826

8.  Integrated detection of extended-spectrum-beta-lactam resistance by DNA microarray-based genotyping of TEM, SHV, and CTX-M genes.

Authors:  Dirk M Leinberger; Verena Grimm; Maya Rubtsova; Jan Weile; Klaus Schröppel; Thomas A Wichelhaus; Cornelius Knabbe; Rolf D Schmid; Till T Bachmann
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

9.  A fluorometric assay for rapid enrichment and determination of bacteria by using zirconium-metal organic frameworks as both capture surface and signal amplification tag.

Authors:  Shuangshuang Yang; Yongcan Guo; Jingchuan Fan; Yujun Yang; Chen Zuo; Shulian Bai; Shangchun Sheng; Junjie Li; Guoming Xie
Journal:  Mikrochim Acta       Date:  2020-02-24       Impact factor: 5.833

10.  Direct identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry.

Authors:  Bernard La Scola; Didier Raoult
Journal:  PLoS One       Date:  2009-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.